FDA Raises Concerns Over How Chinese Drugs are Tested

P.M. Edition for Feb. 9. U.S. regulators are expressing concerns about the quality of studies used to test drugs developed in China, potentially halting plans to sell them in the U.S. WSJ pharmaceutical reporter Peter Loftus joins host Annmarie Fertoli to discuss. Learn more about your ad choices. Visit megaphone.fm/adchoices